YKYY031
/ Youcare Pharmaceutical Group
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
January 31, 2026
Phase I clinical trial of YKYY031 for injection in patients with advanced solid tumors
(ChiCTR)
- P1 | N=76 | Not yet recruiting | Sponsor: Beijing Cancer Hospital; Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd.
New P1 trial • Colorectal Cancer • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1